Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021

被引:3
|
作者
Felzer, Jamie R. [1 ]
Montgomery, Amy J. [2 ]
Lemahieu, Allison M. [3 ]
Rutten, Lila J. Finney [4 ]
Juhn, Young J. [5 ,6 ]
Wi, Chung-Il [5 ,6 ]
Jacobson, Robert M. [4 ,5 ,6 ,7 ]
Kennedy, Cassie C. [1 ,8 ,9 ]
机构
[1] Mayo Clin, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Rochester, MN USA
[3] Mayo Clin, Div Clin Trials & Biostat, Rochester, MN USA
[4] Mayo Clin, Div Epidemiol, Rochester, MN USA
[5] Mayo Clin, Dept Quantitat Hlth Sci, Div Community Pediat Med, Rochester, MN USA
[6] Mayo Clin, Dept Quantitat Hlth Sci, Div Adolescent Med, Rochester, MN USA
[7] Mayo Clin, Div Pediat Infect Dis, Rochester, MN USA
[8] Mayo Clin, Dept Pediat & Adolescent Med, Div Hlth Care Delivery Res, Rochester, MN 55905 USA
[9] Mayo Clin, Resp Hlth Equ Clin Res Lab, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
adult; health care disparities; respiratory tract infections; risk factors; sociodemographic factors; vaccines; MEDICAL-RECORDS-LINKAGE; DATA RESOURCE PROFILE; ADVISORY-COMMITTEE; CONJUGATE VACCINE; UNITED-STATES; SOCIOECONOMIC-STATUS; UPDATED RECOMMENDATIONS; POLYSACCHARIDE VACCINE; DISEASE; HEALTH;
D O I
10.1016/j.chest.2024.01.049
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Despite effective vaccines against in fl uenza, pneumococcus, and COVID-19, uptake has been suboptimal. RESEARCH QUESTION: Although disparities in vaccination by race and ethnicity have been observed, what is the role of other sociodemographic factors in US vaccine uptake? STUDY DESIGN AND METHODS: We conducted a population-based study using the Rochester Epidemiology Project (REP), a comprehensive medical records linkage system, to assess effects of sociodemographic factors including race, ethnicity, individual-level socioeconomic status (SES) via the housing-based socioeconomic status index, education, population density (urban or nonurban), and marital status with uptake of in fl uenza, pneumococcal, and COVID-19 vaccination in high-risk adults. Adults at high risk of invasive pneumococcal disease residing in four counties in southeastern Minnesota who were aged 19 to 64 years were identi fi ed. Vaccination data were obtained from the Minnesota Immunization Information Connection and REP from January 1, 2010, through December 31, 2021. RESULTS: We identi fi ed 45,755 residents. Most were White (82%), non-Hispanic (94%), married (56%), and living in an urban setting (81%), with three-quarters obtaining at least some college education (74%). Although 45.1% were up to date on pneumococcal vaccines, 60.1% had completed the primary COVID-19 series. For in fl uenza and COVID-19, higher SES, living in an urban setting, older age, and higher education positively correlated with vaccination. Magnitude of differences in race, education, and SES widened with booster vaccines. INTERPRETATION: This high-risk population is undervaccinated against preventable respiratory diseases, especially in fl uenza and pneumococcus. Although national data reported improvement of disparities in COVID-19 vaccination uptake observed early in the pandemic, our data demonstrated gaps related to race, education level, SES, and age that widened with booster vaccines. Communities with high social vulnerabilities often show increased risk of severe disease outcomes, yet demonstrate lower uptake of preventive services. This highlights the need to understand better vaccine compliance and access in rural, lower SES, lesseducated, Black, Hispanic, and younger populations, each of which were associated independently with decreased vaccination. CHEST 2024; 166(1):49-60
引用
收藏
页码:49 / 60
页数:12
相关论文
共 50 条
  • [21] Co-Created Messaging for Influenza Vaccination in a High-Risk Hispanic Community Provides Groundwork for COVID-19 Vaccine
    Long, Apple
    Mathew, Sheryl
    Alvarez, Kristin S.
    Smartt, Jillian
    Shah, Monal
    Madden, Christopher
    Perl, Trish M.
    Cerise, Fred P.
    Bhavan, Kavita P.
    HEALTH EQUITY, 2021, 5 (01) : 345 - 352
  • [22] COVID-19 Vaccine Misperceptions in a Community Sample of Adults Aged 18-49 Years in Australia
    Pickles, Kristen
    Copp, Tessa
    Meyerowitz-Katz, Gideon
    Dodd, Rachael H.
    Bonner, Carissa
    Nickel, Brooke
    Steffens, Maryke S.
    Seale, Holly
    Cvejic, Erin
    Taba, Melody
    Chau, Brian
    McCaffery, Kirsten J.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (11)
  • [23] COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021
    Baack, Brittney N.
    Abad, Neetu
    Yankey, David
    Kahn, Katherine E.
    Razzaghi, Hilda
    Brookmeyer, Kathryn
    Kolis, Jessica
    Wilhelm, Elisabeth
    Nguyen, Kimberly H.
    Singleton, James A.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (25): : 928 - 933
  • [24] Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021
    Chung, Jessie R.
    Kim, Sara S.
    Belongia, Edward A.
    McLean, Huong Q.
    King, Jennifer P.
    Nowalk, Mary Patricia
    Zimmerman, Richard K.
    Geffel, Krissy Moehling
    Martin, Emily T.
    Monto, Arnold S.
    Lamerato, Lois E.
    Gaglani, Manjusha
    Hoffman, Eric
    Volz, Marcus
    Jackson, Michael L.
    Jackson, Lisa A.
    Patel, Manish M.
    Flannery, Brendan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (04) : 673 - 679
  • [25] Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh
    Jannat, Zerin
    Das, Hemel
    Ali, Md. Wazed
    Wahed, Tasnuva
    Alam, Md. Nurul
    Uddin, Md. Jasim
    PLOS ONE, 2024, 19 (04):
  • [26] Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data
    Boing, Antonio Fernando
    Boing, Alexandra Crispim
    Barberia, Lorena
    Borges, Marcelo Eduardo
    Subramanian, S. V.
    VACCINE, 2023, 41 (26) : 3937 - 3945
  • [27] Molnupiravir for high-risk adults with COVID-19: Target trial emulation in a Japanese cohort
    Kimura, Yuya
    Matsui, Hiroki
    Ono, Sachiko
    Sato, So
    Yasunaga, Hideo
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (03)
  • [28] COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021
    Hause, Anne M.
    Baggs, James
    Marquez, Paige
    Myers, Tanya R.
    Gee, Julianne
    Su, John R.
    Zhang, Bicheng
    Thompson, Deborah
    Shimabukuro, Tom T.
    Shay, David K.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (51-52): : 1755 - 1760
  • [29] Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil
    Rezende, Leandro F. M.
    Thome, Beatriz
    Schveitzer, Mariana Cabral
    Borges De Souza-Junior, Paulo Roberto
    Szwarcwald, Celia Landmann
    REVISTA DE SAUDE PUBLICA, 2020, 54
  • [30] Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea
    Jang, Hyeongap
    Kim, Joon Hyung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 959 - 966